In the UC group, IBD medications that had ever been used were 5-ASAs (n = 2636, 91.3%), thiopurine (n = 462, 16%), anti-TNF-α agents (n = 16, 0.6%), and corticosteroids (n = 2105, 72.9%; Table 1). The gene discussed is TNF; the disease is inflammatory bowel disease.